ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Upadacitinib: A Pill for Crohn’s Disease David Orchard-Webb
March 01, 2024Recently, the U.S. Food and Drug Administration (FDA) approved a groundbreaking oral medication called Upadacitinib (upadacitinib) for adults with moderately to severely active Crohn's disease.
Pharma Sources Insight January 2025
